Product Information
SOD SULFACE-SULF 9.8-4.8% CLSR is a generic product labeled by Gabar Health Sciences Corp., priced at $0.1681 per GM under NDC 82429010910. Its NADAC has been published 157 times since Jan 4, 2023.
Strength
98; 48 mg/g; mg/g
Manufacturer
Gabar Health Sciences Corp.NDC
82429010910
Classification
Generic
Dosage Form
RINSE
Route
TOPICAL
Effective Date
12/17/2025
Active Ingredients
SULFACETAMIDE SODIUM; SULFURApproval Type
Unapproved
On Market Since
10/10/2022
Pharmacological Classes
Price Statistics
The NADAC for SOD SULFACE-SULF 9.8-4.8% CLSR has been published 157 times since Jan 4, 2023, and over the history we have for it it has declined 69.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1681 per GM |
|---|---|
| All-time high | $0.9302 (Jan 10, 2024) |
| All-time low | $0.1681 (Dec 17, 2025) |
| 52-week high | $0.1942 |
| 52-week low | $0.1681 |
| Median price | $0.4025 |
| Average price | $0.4529 |
| Largest weekly change | +51.7% (May 17, 2023) |
| Weeks tracked | 157 |
| Tracking since | Jan 4, 2023 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-13.5%
3Y
-81.9%
5Y
N/A
All
-69.2%
Last surveyed Dec 31, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Sodium Sulfacetamide, Sulfur market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Gabar Health Sciences Corp. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Sodium Sulfacetamide, Sulfur market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sulfonamide Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SOD SULFACE-SULF 9.8-4.8% CLSR?
The current National Average Drug Acquisition Cost (NADAC) for SOD SULFACE-SULF 9.8-4.8% CLSR, manufactured by Gabar Health Sciences Corp., is $0.1681 per GM (NDC 82429010910), effective Dec 31, 2025.
How has the price of SOD SULFACE-SULF 9.8-4.8% CLSR changed over time?
Over the history we have for it, the NADAC for SOD SULFACE-SULF 9.8-4.8% CLSR has declined 69.2%. It has been tracked across 157 weekly CMS publications since Jan 4, 2023.
What are the highest and lowest recorded NADAC prices for SOD SULFACE-SULF 9.8-4.8% CLSR?
Since Jan 4, 2023, the NADAC for SOD SULFACE-SULF 9.8-4.8% CLSR has ranged from a low of $0.1681 (Dec 17, 2025) to a high of $0.9302 (Jan 10, 2024), with a median of $0.4025 per GM.
Are there cheaper alternatives to SOD SULFACE-SULF 9.8-4.8% CLSR?
No other NADAC-published product currently shares the active ingredient and strength of SOD SULFACE-SULF 9.8-4.8% CLSR in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures SOD SULFACE-SULF 9.8-4.8% CLSR?
SOD SULFACE-SULF 9.8-4.8% CLSR (NDC 82429010910) is labeled by Gabar Health Sciences Corp., and CMS classifies it as a generic product.